NIAID researchers are investigating the acquired causes of bronchiectasis, which is characterized by enlarged airways that are chronically infected with bacteria and predisposes people to infection. If you have been diagnosed with or are showing signs of bronchiectasis, you may be eligible to participate in an NIAID clinical study. There is no charge for study-related medical care, including study visits, medications, treatments, and procedures. Volunteers also may be compensated for time and travel.
The following are selected studies sponsored by NIAID. The links lead to full descriptions and study locations.
Arikace for Nontuberculous Mycobacteria (NCT01315236)This study is enrolling people ages 18 to 85 who have been diagnosed with treatment refractory pulmonary nontuberculous mycobacterial lung disease with evidence of nodular bronchiectasis and/or cavitary disease. This study evaluates the effectiveness and safety of Arikace treatment.
Cross-sectional Characterization of Idiopathic Bronchiectasis (NCT01264055)This study is enrolling volunteers at least 18 years of age who have a chronic cough and who have had a CT scan that revealed signs of bronchiectasis. This study attempts to broaden the understanding of this disease.
Natural History of Bronchiectasis (NCT00943514)This study is enrolling volunteers 5 years of age and older who have been diagnosed with bronchiectasis or have a history of chronic/recurring respiratory infections. This study explores the causes of and mechanisms for the development of bronchiectasis in patients with chronic and recurring respiratory tract infections.
Patient Recruitment and Public Liaison OfficeToll Free: 1-800-411-1222TTY: 1-866-411-1010Se habla español.Email: email@example.com
NIAID participates in the U.S. Bronchiectasis Research Registry to support collaborative research and assist in the planning of multicenter clinical trials for the treatment of non-cystic fibrosis bronchiectasis. Read more about the U.S. Bronchiectasis Research Registry.
Last Updated March 04, 2013